Low Molecular Weight Heparin Vs Direct Oral Anticoagulants (Apixaban, Edoxaban and Rivaroxaban) for the Treatment of Cancer Associated Thrombosis: A Cost- Effective Analysis

被引：0
|
作者：
Gulati, Shuchi [1 ]
Elsisi, Zizi [2 ]
Deoghare, Smruti [2 ]
Eckman, Mark [2 ]
机构：
[1] Univ Cincinnati, Vontz Ctr Mol Studies, Cincinnati, OH USA
[2] Univ Cincinnati, Cincinnati, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124756
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
328
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Recio-Boiles, Alejandro
    Veeravelli, Sumana
    Vondrak, Jessica
    Babiker, Hani M.
    Scott, Aaron J.
    Shroff, Rachna T.
    Patel, Hitendra
    Elquza, Emad
    McBride, Ali
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 866 - 876
  • [42] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Alejandro Recio-Boiles
    Sumana Veeravelli
    Jessica Vondrak
    Hani M Babiker
    Aaron J Scott
    Rachna T Shroff
    Hitendra Patel
    Emad Elquza
    Ali McBride
    World Journal of Gastrointestinal Oncology, 2019, 11 (10) : 866 - 876
  • [43] The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
    Al-Samkari, Hanny
    Connors, Jean M.
    CANCERS, 2018, 10 (08):
  • [44] Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China
    Wu, Yue
    Yin, TianChen
    Jian, Guilin
    Wan, Tao
    Zhou, BenHong
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
    Munoz, Andres
    Gallardo, Enrique
    Agnelli, Giancarlo
    Crespo, Carlos
    Forghani, Monica
    Arumi, Daniel
    Fernandez de Cabo, Susana
    Soto, Javier
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 840 - 847
  • [46] COST-UTILITY ANALYSIS COMPARING DIRECT ORAL ANTICOAGULANT (DOAC) AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) THERAPIES FOR CANCER-ASSOCIATED THROMBOSIS (CAT) TREATMENT IN THE UNITED STATES
    Shin, Y. E.
    Hwang, M.
    Mackey, M. L.
    Kumar, A.
    Wu, W. K.
    VALUE IN HEALTH, 2022, 25 (07) : S433 - S433
  • [47] A retrospective single-center evaluation of the safety and efficacy of direct oral anticoagulants versus low molecular weight heparin in patients with cancer-associated thrombosis.
    McShane, Melissa
    Senchak, Jordan
    Stack, Anthony
    Frimpong, Justina
    Hellerslia, Van T.
    Zhao, Huaqing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis
    Soff, Aaron P.
    Dong, Judy
    Dong, Aiqi
    Devlin, Sean
    Mantha, Simon
    Parameswaran, Rekha
    Soff, Gerald A.
    BLOOD, 2015, 126 (23)
  • [49] Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study
    Reed-Guy, Lauren
    Desai, Arati S.
    Phillips, Richard E.
    Croteau, Desiree
    Albright, Karen
    O'Neill, Meghan
    Brem, Steven
    O'Rourke, Donald M.
    Amankulor, Nduka M.
    Bagley, Stephen J.
    NEURO-ONCOLOGY, 2022, 24 (12) : 2172 - 2179
  • [50] Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis
    Patel, Tirath
    Nadeem, Taha
    Shahbaz, Usman
    Tanveer, Fatima
    Ahsan, Muneeb
    Saeed, Usman
    Ahmed, Abdullah
    Kumar, Vinesh
    Jaffari, Syed M. Ibne Ali
    Zaman, Mohammad U.
    Kumar, Satesh
    Khatri, Mahima
    Varrassi, Giustino
    Vanga, Prasanthi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
12345